I’ve been diving deeper into how CRISPR technology is shaping the future of genetic research and its potential impact on equity in healthcare. It raises some ethical questions that we need to address — like how do we ensure access to these advanced treatments across different socioeconomic groups? It’s fascinating but also a bit daunting.